A20 as a potential new tool in predicting recurrence and patient’s survival in oral squamous cell carcinoma

HIGHLIGHTS

• who: Steffen Spoerl and colleagues from the Department of Cranio-Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany have published the Article: A20 as a Potential New Tool in Predicting Recurrence and Patientu2019s Survival in Oral Squamous Cell Carcinoma, in the Journal: Cancers 2023, 15, x FOR PEER REVIEW of /2023/
• what: A limitation of this study is certainly the retrospective approach that needs to be further evaluated in consecutive, prospective clinical trials. This work characterizes A20 as a novel prognostic biomarker in OSCC.
• future: Especially due to the predominant expression of A20 on . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.